Pricing

Radius Health Inc (RDUS)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
George K. Martin
Employees:
290
ATTN: PRINCIPAL FINANCE OFFICER, 22 BOSTON WHARF ROAD, 7TH FLOOR, BOSTON, MA, 02210
617-551-4000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • RADIUS HEALTH INC COM
  • RADIUS HEALTH INC COM
  • RADIUS HEALTH INC COM 01/17/20122

Are you looking for this stock instead?

The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. The company is also developing a transdermal system that is in Phase III clinical trials to treat post menopausal women. It has collaborations and license agreements with 3M Company, Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd. and Duke University.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available